Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin (Q65393479)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin |
clinical trial |
Statements
Phase II Study of Cisplatinum and Everolimus in Patients With Metastatic or Unresectable Neuroendocrine Carcinomas (NEC) of Extrapulmonary Origin (English)
0 references
30 March 2016
0 references
January 2019
0 references
39
0 references
18 year
0 references